ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

NCT03897543 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: ABX196

Sponsor

Abivax S.A.

Collaborators

[object Object]